Skip to main content
. 2021 Dec 2;13(23):6073. doi: 10.3390/cancers13236073

Figure 3.

Figure 3

Figure 3

(a) Progression-free survival and (b) overall survival of the patients with de novo and transformed DLBCL. Progression-free survival of (c) patients with transformed lymphoma who reached a complete remission (CR) and who did not; and (d) of patients with de novo lymphoma who reached a CR and who did not. Overall survival of (e) patients with transformed lymphoma who reached a CR and who did not and (f) of patients with de novo lymphoma who reached a CR and who did not.